Norgine completes acquisition of Theravia

15-Aug-2025 - Norgine announced the successful completion of the acquisition of Theravia, an international pharmaceutical company specializing in therapies for patients with rare and serious diseases. The completion of this acquisition is an important step for Norgine towards its goal of bringing life-changing ...

Cannovum Health welcomes new strategic majority investor

12-Aug-2025 - Cannovum Health GmbH celebrates a key milestone in its corporate development: Triple Crown Ventures becomes the new majority investor. With this step, the company gains a financially strong and strategic partner who firmly believes in Cannovum Health’s vision. In addition to increasing Cannovum ...

BINDER acquires Parameter Generation & Control

01-Aug-2025 - BINDER is pleased to announce the acquisition of Parameter Generation & Control, a U.S.-based manufacturer specializing in Walk-In humidity and temperature control systems. This strategic acquisition enhances BINDER’s product portfolio andstrengthens the company’s positionin delivering ...

ZEISS acquires all equity shares of Pi Imaging Technology SA

Unlocking SPAD technology for advanced imaging applications in microscopy and beyond

22-Jul-2025 - In early July, Carl Zeiss Microscopy GmbH has acquired all equity shares of Pi Imaging Technology SA, based in Lausanne, Switzerland. Pi Imaging Technology SA now operates as "Pi Imaging Technology SA – a ZEISS company". The Lausanne location with all employees will be retained. Pi Imaging ...

Siemens completes acquisition of Dotmatics

Acquisition expanding Siemens’ offerings into the life sciences industry

03-Jul-2025 - Siemens AG announced today that it has completed the acquisition of Dotmatics, a leading provider of Life Sciences R&D software headquartered in Boston and portfolio company of global software investor Insight Partners, for an enterprise value of $5.1 billion. With the transaction now completed, ...

Merck Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business

It represents one of the biggest M&A deals in the global biopharma sector so far in 2025

03-Jul-2025 - Merck announced that it has closed the acquisition of SpringWorks Therapeutics, Inc., for an enterprise value of $3.4 billion (approximately €3 billion)*, following regulatory clearances and the fulfillment of other customary closing conditions. The definitive agreement between Merck and ...

Biontech wants to acquire Curevac

Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates

13-Jun-2025 - BioNTech SE and CureVac N.V. announced that they have entered into a definitive Purchase Agreement pursuant to which BioNTech intends to acquire all of the shares of CureVac, a clinical-stage biotech company developing a novel class of transformative medicines in oncology and infectious diseases ...

Bruker Announces Acquisition of biocrates

The acquisition further enhances Bruker’s MS-based metabolomics solutions

05-Jun-2025 - Bruker Corporation announced the acquisition of biocrates life sciences ag, located in Innsbruck, Austria. Financial terms were not disclosed. biocrates is a leader in mass spectrometry (MS)-based quantitative metabolite and lipid analysis kits, assays, software and services that make ...

Infrareal takes over Takeda’s pharmaceutical and biotech site in Orth

The acquisition of the Orth pharmaceutical and biotech site represents a significant milestone in Infrareal Group’s expansion strategy

04-Jun-2025 - Infrareal Holding GmbH & Co. KG announced the completion of its acquisition of the pharmaceutical and biotech site in Orth, Lower Austria. Through its subsidiary PharmaparkOrth Management GmbH, Infrareal is acquiring the 24-hectare site from Takeda including buildings, infrastructure and several ...

Merck to Acquire US Biopharma Company SpringWorks Therapeutics

Planned acquisition will immediately add revenue and accelerate mid- to long-term growth for Merck’s Healthcare business

29-Apr-2025 - Merck and SpringWorks Therapeutics, Inc., a Stamford, Connecticut-based commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced the companies have entered into a definitive agreement for Merck to acquire SpringWorks. The purchase price of $47 per share in ...